Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: uniQure N.V., 3 years.
uniQure N.V.
Director
Cullinan Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | uniQure N.V. | Open-market sale | −1,993 | $27.06 | $53,931 |
| Jun 10, 2026 | uniQure N.V. | Grant or award | +7,550 | — | — |
| Jun 20, 2025 | uniQure N.V. | Open-market sale | −2,112 | $14.45 | $30,518 |
| Jun 11, 2025 | uniQure N.V. | Grant or award | +7,970 | — | — |
| Jun 19, 2024 | uniQure N.V. | Grant or award | +8,080 | — | — |
| Jun 13, 2024 | uniQure N.V. | Open-market sale | −2,229 | $5.12 | $11,412 |
| Jun 16, 2023 | uniQure N.V. | Open-market sale | −2,290 | $18.85 | $43,167 |
| Jun 13, 2023 | uniQure N.V. | Grant or award | +8,700 | — | — |
| Feb 27, 2023 | uniQure N.V. | Open-market sale | −389 | $19.71 | $7,667 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.